Sign in

CIK 0001840439

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Biomea Fusion, Inc.

Sign in to watch
Ticker
BMEA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-980-9099
Business address
1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award Chief Financial Officer acquired 4,273 shares (grant or award)
  4. 4 Open-market sale 10% owner sold 125,000 shares at an average $34.11 ($4,263,915)
  5. 4 Open-market sale 10% owner sold 25,000 shares at $33.84 ($846,000)
  6. 4 Open-market sale 10% owner sold 250,000 shares at an average $34.30 ($8,575,030)
  7. 4 Open-market sale 10% owner sold 200,000 shares at $29.12 ($5,823,760)
  8. 4/A Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
  9. 4 Open-market sale 10% owner sold 200,000 shares at $31.25 ($6,250,000)
  10. 4 Open-market buy Director bought 400,000 shares at $30.00 ($12,000,000)
  11. 5 Insider Annual Insider Trading Report
  12. 4/A Open-market buy President and COO bought 8,400 shares at $17.00 ($142,800)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award Chief Financial Officer acquired 2,518 shares (grant or award)
  17. 4 Open-market buy Director bought 5,000 shares at $7.93 ($39,650)
  18. 4 Open-market buy Chief Financial Officer bought 4,100 shares at $7.63 ($31,286)
  19. 4 Open-market buy 10% owner bought 30,684 shares at $13.87 ($425,648)
  20. 4 Open-market sale 10% owner sold 34,658 shares at $11.21 ($388,516)

Page 3 of 5 · 98 filings